| Mr Mark Edward English Jr, MD | |
|
4401 Campus Ridge Dr Ste Ll110, Midland, MI 48640-6126 | |
| (989) 837-9400 | |
| Not Available |
| Full Name | Mr Mark Edward English Jr |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 4401 Campus Ridge Dr Ste Ll110, Midland, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205499845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301508905 (Michigan) | Primary |
| Entity Name | Mymichigan Medical Center Midland |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205889490 PECOS PAC ID: 2264323633 Enrollment ID: O20040324000137 |
News Archive
Therefore, the nose is an important target for prophylaxis and also for therapy. In a recent study posted to the bioRxiv* preprint server, Fabio Fais et al. developed a safe and easy-to-use nasal spray, AM-301, a medical device marketed as Bentrio, to protect against infection by SARS-CoV-2 and potentially other viruses.
Today's headlines include health policy headlines from Capitol Hill and from the insurance markeplace.
According to the latest report by the Australian Institute of Health and Welfare (AIHW) hospital admissions have risen significantly up to 16 percent from 2004 to 2009. Admissions in 2008 and 2009 amounted to a whopping 8 million and the report author George Bodilsen felt that multiple factors are responsible for this growing pressure on the nation's hospitals. "The increase in hospital activity is a reflection of the increasing population, the ageing population, and perhaps the increase in chronic diseases in the population as we age," he said.
Penwest Pharmaceuticals Co. today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc. under which Penwest and Alvogen have agreed to identify and select up to five compounds for generic development. Penwest's TIMERx technology may be used for each compound selected.
The cover for issue 52 of Oncotarget features Figure 1, "Volcano plots of DNA methylation in tumor tissues compared with nontumor tissue," published in "Reduction of T-Box 15 gene expression in tumor tissue is a prognostic biomarker for patients with hepatocellular carcinoma" by Morine, et al. which reported that the authors conducted a genome-wide analysis of DNA methylation of the tumor and non-tumor tissue of 15 patients with Hepatocellular carcinoma (HCC), and revealed TBX15 was the most hypermethylated gene of the tumor.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Mark Edward English Jr, MD 4000 Wellness Dr, Midland, MI 48670-2000 Ph: () - | Mr Mark Edward English Jr, MD 4401 Campus Ridge Dr Ste Ll110, Midland, MI 48640-6126 Ph: (989) 837-9400 |
News Archive
Therefore, the nose is an important target for prophylaxis and also for therapy. In a recent study posted to the bioRxiv* preprint server, Fabio Fais et al. developed a safe and easy-to-use nasal spray, AM-301, a medical device marketed as Bentrio, to protect against infection by SARS-CoV-2 and potentially other viruses.
Today's headlines include health policy headlines from Capitol Hill and from the insurance markeplace.
According to the latest report by the Australian Institute of Health and Welfare (AIHW) hospital admissions have risen significantly up to 16 percent from 2004 to 2009. Admissions in 2008 and 2009 amounted to a whopping 8 million and the report author George Bodilsen felt that multiple factors are responsible for this growing pressure on the nation's hospitals. "The increase in hospital activity is a reflection of the increasing population, the ageing population, and perhaps the increase in chronic diseases in the population as we age," he said.
Penwest Pharmaceuticals Co. today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc. under which Penwest and Alvogen have agreed to identify and select up to five compounds for generic development. Penwest's TIMERx technology may be used for each compound selected.
The cover for issue 52 of Oncotarget features Figure 1, "Volcano plots of DNA methylation in tumor tissues compared with nontumor tissue," published in "Reduction of T-Box 15 gene expression in tumor tissue is a prognostic biomarker for patients with hepatocellular carcinoma" by Morine, et al. which reported that the authors conducted a genome-wide analysis of DNA methylation of the tumor and non-tumor tissue of 15 patients with Hepatocellular carcinoma (HCC), and revealed TBX15 was the most hypermethylated gene of the tumor.
› Verified 9 days ago
Mrs. Kelly Marie Hamilton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4401 Campus Ridge Dr Ste Ll110, Midland, MI 48640 Phone: 989-837-9400 Fax: 989-837-9410 | |
Paula Reif Headbloom, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3306 Thornbrook Ct, Midland, MI 48640 Phone: 989-859-1233 Fax: 989-631-4960 | |
Cheryl Dwyer, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4320 Campus Ridge Drive, Midland, MI 48640 Phone: 989-839-3170 Fax: 989-839-1840 | |
Dr. Elvira Mikhailovna O'brien, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4401 Campus Ridge Dr Ste Ll110, Midland, MI 48640 Phone: 989-837-9400 Fax: 989-837-9410 | |
Dr. David Allen Junge, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4009 Orchard Drive, Suite #3025, Midland, MI 48640 Phone: 989-631-7913 Fax: 989-631-5798 | |
Dr. Sandeep Sambrani Rao, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4401 N Campus Ridge Dr, #b2200, Midland, MI 48640 Phone: 989-837-9400 |